Chicago Immunoengineering Innovation Center - Immunoengineering Work-in-Progress Seminar Series

When:
Wednesday, January 31, 2024 1:00 pm - 2:00 pm
Where:
ERC 161
Description:

Sheridan Swan | Swartz & Hubbell Labs - “Enhancing lymphangiogenesis-inducing whole tumor cell vaccines by improving systemic immunity.”

Nicholas Asby | Huang Lab - “Expression of a chimeric coreceptor enhances antitumor immunity of CD22-targeted CAR-T cells."